16 Oct GEHC Stock Price – Get the Latest Update!
Did you know GE HealthCare Technologies Inc. (GEHC) rose by 34.13% last year? It’s now worth nearly $41.84 billion USD. This big healthcare company is making a splash in the financial world1. People investing in stocks are keeping an eye on GEHC’s latest prices to stay updated.
Getting the scoop on the latest GEHC stock price helps you with smart investing. It’s good for both new and experienced investors. By monitoring the general electric healthcare stock, you get insights into its financial path. Recent results are impressive, with a 0.52% jump from last week and a 4.73% increase over the month1. Now’s a great time to look into GEHC’s stock performance.
Key Takeaways
- GEHC’s value is $41.84 billion USD1.
- Its stock has gone up 34.13% in a year1.
- A look at recent numbers shows a 0.52% increase last week and 4.73% this month1.
- The company offers a dividend yield of 0.13%1.
- Basic earnings per share (EPS) stand at $3.47 USD1.
Introduction to GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a top player in the medical tech and pharmaceutical diagnostics field. It works hard to make healthcare better, aiming to enhance patient care with cutting-edge solutions.
Company Overview
The company started with a goal to lead in healthcare innovations. It’s now worth 41.84 billion USD and has 51,000 employees globally1. Based in Chicago, Illinois, GE Healthcare is all in on crafting top-notch tech and services. These efforts help medical pros offer great care.
Key Segments
GE HealthCare Technologies Inc. shines through its important business areas. These sectors play a big part in its success. They are:
- Imaging: Delivers cutting-edge image tech for better diagnosis and treatment.
- Ultrasound: Offers creative ultrasound tech in many medical areas.
- Patient Care Solutions (PCS): Brings together solutions that boost patient care quality.
- Pharmaceutical Diagnostics (PDx): Provides key diagnostic agents for imaging tests.
Focused on these areas, GE Healthcare leads its field and keeps financial strength1. It keeps sharpening its competitive edge to grow in a tough healthcare market.
Check out this detailed GEHC stock analysis for market insights. It offers key assessments vital for investors.
Current GEHC Stock Price Data
For investors wanting to do well, knowing the latest GEHC stock price is key. Let’s look at the main numbers showing how GE HealthCare Technologies Inc.’s stock is doing.
Recent Closing Prices
The recent closing price for GEHC was $91.62. It opened at $91.89 the next day. This shows a small change within the day, where prices moved from $90.61 to $91.962.
From June to October 2024, the closing prices mostly stayed between $80.00 and $90.00. This points to a stable trend3. The highest price hit was $94.55 on September 27, 2024, marking a significant moment3.
About 2,500,0003 stocks are traded each day. This shows GE HealthCare Technologies Inc. keeps attracting investor attention.
52-Week Range
Looking at the 52-week range gives us an idea about stock price changes. The lowest price for GEHC was $62.35, and the highest was $94.552. This big gap tells us the stock’s price can really vary.
The volatility of the stock price is around 1.48%. This tells us the market is always changing1. On April 30, 2024, a huge number of stocks, 14,433,600, were traded. This was a day of very high trading activity3.
Knowing these details helps when making investment choices in GE HealthCare Technologies Inc. Keeping an eye on the GEHC stock quote lets you adjust your investment plans with the market.
| Metric | Value |
|---|---|
| Highest Stock Price | $94.553 |
| Lowest Stock Price | $62.352 |
| Day’s Range | $90.61 – $91.962 |
| Average Daily Volume | 2,500,0003 |
| Largest Daily Volume | 14,433,6003 |
GEHC Stock Performance Analysis
Delving into GEHC stock performance offers useful insight for potential investors. Looking at the 1-year and year-to-date (YTD) returns helps us understand its recent success.
1-Year Return
The past year was great for GE HealthCare Technologies Inc. It showed strong financial health and kept a solid place in the market. With an intraday market cap of $41.424 billion2, it proves the company is stable and trusted by investors.
YTD Return
So far this year, GEHC stock performance has been encouraging. It’s been fueled by steady returns and smart growth strategies. With a price-to-earnings (PE) ratio of 26.222 and earnings per share (EPS) of $3.462, investors have seen a solid GEHC return on investment.
Furthermore, a forward dividend yield of 0.13%2 and a return on equity (TTM) of 21.22%2 maintain the company’s appeal. These numbers show GE HealthCare Technologies Inc.’s strong financial health and its focus on shareholder value.
Latest GEHC Stock News
Keep up with the latest GEHC stock news to make smart investment choices. As of October 15, 2024, GE HealthCare Technologies (GEHC) has a stock price of $90.714. The company has a significant market cap of about $41.4 billion4, showing its big role in the healthcare field.
The GE HealthCare stock saw a 14% fall recently5. Despite the drop, GE HealthCare maintains strong financial health with steady revenue growth4. Its Imaging segment is the leading source of this income4. GE HealthCare is also pushing forward with AI in medical imaging to better patient care4.
The company is working together with health providers and research groups to spark new ideas. These efforts have improved their offerings, like imaging machines, ultrasound equipment, monitoring systems, and diagnostic solutions4. With the AI in Healthcare market expected to hit $613 billion by 20345, they’re on track for growth.
Staying informed on General Electric healthcare stock news is key for anyone invested. With GE HealthCare’s solid standing and ongoing innovation, its future looks bright. This is crucial in the ever-changing healthcare industry.
GEHC Stock Forecast
Analysts provide insights that are key for investors looking at the GEHC stock forecast. These views help people decide how to invest in GEHC stocks wisely.
Analyst Recommendations
Recent data shows GE HealthCare Technologies Inc. with an average rating of 1.84 out of 5. It has 12 strong buy ratings, 6 hold ratings, and 1 strong sell rating6. It holds a Zacks Rank of 3-Hold, showing analysts have mixed opinions on its future6. The current stock price is $90.71 USD. This is a slight drop of -0.99% from before6.
1-Year Target Estimates
Analysts see a potential rise in GEHC stock to an average of $96.44. This suggests a 6.32% gain from its current price6. Predictions for the stock span from a low of $74.00 to a high of $110.006. The close 1-year estimate is $96.142. With a market cap of $41.424 billion and a PE ratio of 26.22, GEHC shows signs of stability and growth2.
Here’s a detailed table of the analyst recommendations and 1-year target estimates:
| Metric | Value |
|---|---|
| Average Brokerage Recommendation | 1.84/5 |
| Zacks Rank | 3-Hold |
| Average Price Target | $96.44 |
| Highest Price Target | $110.00 |
| Lowest Price Target | $74.00 |
| 1-Year Target Estimate | $96.14 |
Market Factors Affecting GEHC Stock Price
Investors find great value in knowing what affects GEHC stock price. Key factors include how well it does in its sector. Right now, GE HealthCare Technologies Inc.’s stock is $76.24. This is a drop of 14.28% from its last close of $88.947. It’s marked as pricey with a D Value Grade. Also, this month, the stock went down by 16.14%, hitting a high of $91.46 and a low of $76.087.
Market analysis looks at industry trends too. The P/E ratio for GE HealthCare is 29.3, below the industry’s 36.7 median7. This could mean the company is underrated compared to others. The stock’s value went up by 30.59% this year, showing good market momentum7. Analyst ratings for GE HealthCare improved last month, which matters7.
Corporate actions impact GEHC price as well. After spinning off, GE gave out about 80.1% of GE HealthCare’s common stock shares to its shareholders. It kept about 19.9%8. This move affected how investors see the company and its market value. GE HealthCare’s shares are now on The Nasdaq Stock Market LLC, under the symbol “GEHC”8.
Another key factor for investors is Relative Price Strength. GE HealthCare Technologies Inc. has a relative price strength of 1.34%. Its Momentum Score is 70, showing strength according to AAII7. The stock’s performance is also shaped by the overall economy and specific industry events.
| Market Factors | Impact on GEHC Stock Price |
|---|---|
| Current Stock Price | $76.24 (decline of 14.28%)7 |
| Industry Median P/E Ratio | 36.7 (GEHC: 29.3)7 |
| Year-To-Date Performance | Up 30.59%7 |
| Analyst Upgrades | 1 upgrade in the last month7 |
| Spin-Off Distribution | 80.1% distributed, 19.9% retained8 |
To sum up, knowing what drives GEHC stock is crucial for smart investing. Things like company events, market trends, and economic signs all influence GE HealthCare Technologies Inc.’s stock.
GEHC Financial Highlights
Let’s dive into GEHC HealthCare Technologies Inc. (GEHC) financial condition. We check its profit and revenue to understand its economic status. These figures shine a light on how well GEHC is doing.
Profit Margin
GEHC keeps 8.09% of its earnings as profit, showing it’s good at making money from its sales2. This number is key in seeing how well it does against other health companies. It tells us GEHC is smart in spending and operations, which helps its finances.
Total Revenue
Recently, GEHC made $19.52 billion2. This big amount shows GEHC’s strong position in the health market. It’s important for investors because it shows GEHC can earn well from what it does. It also hints at GEHC’s growth and size in the industry.
In short, GEHC’s financial details show it is doing well in terms of profit and earnings. This confirms its solid spot in the market and healthy finances.
Investment Opportunities with GEHC Stock
Investing in GEHC means exploring the medical technology and pharmaceutical diagnostics fields. This company has a market value of 41.424 billion USD, making it a big name in the industry2. Another thing boosting GEHC stock is its 8.09% profit margin, showing it can really make money2.
GEHC stands out with a 21.22% return on equity, showing it’s good at making money with what investors give2. Its 5.73% return on assets shows the company uses its resources wisely2.
The PE Ratio (TTM) of 26.22 indicates GEHC is valued well against its earnings2. Also, its EPS of 3.46 adds to the stock’s appeal for investors2.
GEHC’s revenue of 19.52 billion USD points to a strong financial base and growth potential2. A 0.13% forward dividend yield offers an earnings chance while eyeing stock value rise2.
Overall, GEHC offers great returns through strong financial health and market stance. Its strategic resource and equity use, alongside steady revenue, make GEHC stock a top pick for those eyeing the medical and pharmaceutical tech sectors.
| Metric | Value |
|---|---|
| Market Capitalization | 41.424 billion USD |
| PE Ratio (TTM) | 26.22 |
| EPS (TTM) | 3.46 |
| Profit Margin | 8.09% |
| Return on Assets | 5.73% |
| Return on Equity | 21.22% |
| Revenue (TTM) | 19.52 billion USD |
| Total Cash (MRQ) | 2 billion USD |
| Dividend Yield | 0.13% |
GEHC Stock Valuation Metrics
When you look into GEHC stock, you examine essential metrics to decide on your investment. It’s vital to understand the Price/Earnings (P/E) ratio and the Price/Sales (P/S) ratio. These help make smart investment choices.
Price/Earnings Ratio
The Price/Earnings (P/E) ratio is a key sign of how the market sees GE HealthCare Technologies Inc.’s earnings. Currently, GEHC’s P/E ratio is 26.4x. This is below the industry’s average of 37x, which might mean it’s a good investment chance9. Experts have also found GEHC’s P/E ratio should be around 35.6x. This suggests the stock might be undervalued at its current price9. GEHC’s EPS (TTM) is 3.46, which further suggests now might be a good time to invest2.
Price/Sales Ratio
The Price/Sales (P/S) ratio is also important for understanding GEHC’s value compared to its sales. GE HealthCare Technologies Inc. has a large market cap of $41.57 billion, showing its strong market place9. The enterprise value to revenue ratio is at 2.5x. With an annual revenue around $41.4 billion, it’s set on a strong base for long-term investments10. Also, GEHC’s forward dividend and yield are $0.12 (0.13%), offering a steady income for its investors2.
Assessing GEHC with metrics like the P/E and P/S ratios helps investors figure out the stock’s value. Given GEHC’s expected fair value, its current trading price, and market cap, this healthcare tech leader is likely a solid investment choice.
Key Events Impacting GEHC Stock
In the past year, several events have affected GEHC stock. A major one was the announcement of plans to restructure the company. This move aimed to boost how the company works and has been vital in making better use of resources. It helped GE HealthCare Technologies Inc. see strong growth, with revenues hitting $18.34 billion in 202211.
New products have been key in raising GEHC stock price. The focus on creating new medical technologies has led to exciting new products. These are a result of the company’s heavy investment in research and innovation, supported by strong money flow11.
Building partnerships has also strengthened GE HealthCare Technologies Inc.’s place in the market. Working with big names like Siemens Healthineers and Philips Healthcare has grown GEHC’s offerings. These alliances are crucial for competing in the fast-moving medical tech world11.
GEHC is also reaching out to new health markets globally. Its wide range of products helps it meet the growing need for innovative health solutions in various regions. This effort is in line with the sector’s growth, which includes tech advancements and personalized care11.
Moreover, a forward-looking price-to-earnings-growth ratio of 3 shows GE HealthCare is in a good spot for continued growth11. These numbers show investors feel positive about the company’s future earnings. So, knowing these events is key for in-depth stock analysis of General Electric Healthcare.
Insider Insights: Management Team and Company Leadership
GE Healthcare Technologies Inc. has a dynamic team leading the way. They focus on innovation and growing the company. Learning about their management and decisions shows us the depth of GEHC’s leadership.
Key Executives
Peter J. Arduini is the CEO guiding GE Healthcare. His vast experience in health and tech helps the company. With his leadership, GE Healthcare improves technologies and reaches over 140 countries10. CFO Helmut Zodl oversees the company’s financial strategies. He ensures the company stays profitable, showing an 8.10% profit. This is all backed by a solid financial base12.
Leadership Strategy
The leadership strategy at GEHC focuses on being innovative and precise. By using AI and data analytics, they’ve improved their products and operations. This can be seen in their wide range of products and progress in digital solutions10. These efforts by GEHC’s leaders show how they’re keeping the company competitive and at the front of the market.
Comparative Analysis: GEHC vs. Competitors
GE HealthCare Technologies Inc. shines in many ways when compared to its rivals. For example, last week, GEHC was mentioned in 6 more media articles than Koninklijke Philips—getting 10 mentions against 4 for Philips. Additionally, GEHC’s media sentiment score of 1.10 beats Philips’ score of 0.8113.
Financially speaking, GEHC has an annual dividend of $0.12 and a yield of 0.1%, which is quite different from Philips’ $0.91 dividend and 2.8% yield13. GEHC also shows a strong return on equity of 25.26%. In contrast, Philips has more outperform votes but fewer shares owned by institutional investors—13.7% versus GEHC’s 82.1%13.
GE HealthCare Technologies reports an 8.10% net margin. This is much better than Koninklijke Philips’ -2.35% margin. GEHC is also more volatile than the S&P 500, with a beta of 1.18. Philips, however, is 26% less volatile, with a beta of 0.7413. GEHC also outperforms Philips in 17 out of 21 compared factors13.
General Electric Healthcare operates in four areas: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics14.
GEHC’s stock looks promising, trading 25.2% below its fair value14. The company’s earnings are expected to grow by 12.61%14. In the last 11 months, GEHC’s stock increased by 4.74%. It rose by 10.15% in the past 3 months and 36.11% over the last year14.
| Company | Dividend (Annual) | Dividend Yield | Net Margin | Return on Equity | Media Sentiment Score |
|---|---|---|---|---|---|
| GE HealthCare Technologies | $0.12 | 0.1% | 8.10% | 25.26% | 1.10 |
| Koninklijke Philips | $0.91 | 2.8% | -2.35% | N/A | 0.81 |
| Standard & Poor’s 500 | N/A | N/A | N/A | N/A | N/A |
GEHC also boasts a lower weekly price volatility of 3.2% compared to the Medical Equipment Industry’s 8.4% and the market average of 6.3%14.
As for stock performance, GEHC’s stock has seen stable fluctuations. It now trades at $90.71, showing a -0.99% change. This mirrors the average price change for healthcare stocks on September 2615. Meanwhile, competitor stocks like XLV, MS, and UBS have their own price changes15.
Historical GEHC Stock Trends
Looking at the historical performance of GEHC stock can give you insights into its market behavior. This information not only shows past patterns but can also help predict future trends.
Intraday data for GE HealthCare Technologies has been around for a decade, important for short-term trading plans16. You can access daily data from January 1, 2000, giving a clear picture of long-term shifts in the market16.
Weekly, monthly, and quarterly data since January 1, 1980, reveal GEHC’s long-term market trends more clearly16. By looking at these time frames, you can see GEHC’s stock growth or recurring patterns.
As of October 15, 2024, GE HealthCare Technologies is valued at $41.84 billion, showing its major market impact17. This is backed by annual revenues of $19.552 billion, highlighting its strong position17.
The stock price has fluctuated over time. For instance, it hit a high of $89.18 on April 29, 2024, and a low of $72.61 on February 5, 20243. This range gives investors insights on when to buy or sell.
Major corporate events often lead to high trading volumes. For example, 14,433,600 shares were traded on April 30, 20243. These trades can greatly influence the stock’s price and how it’s seen in the market.
For a closer look at GE HealthCare’s stock trends, check out their historical data. This knowledge is key for making smart investment choices in the GEHC market.
Here’s how GE HealthCare Technologies compares to other healthcare companies:
| Company | Market Cap (Billions) | PE Ratio |
|---|---|---|
| GE HealthCare Technologies | 41.839 | – |
| Inspire Medical Systems | 6.276 | 1169.22 |
| Privia Health | 2.123 | 148.00 |
| Tempus AI | 7.827 | 0.00 |
Comparing GEHC with other healthcare firms shows different market values and metrics17. Reviewing these helps understand GEHC’s industry standing and guides financial choices.
Staying on top of market assessments will keep you informed about GEHC’s stock trends. This helps in crafting investment strategies that meet your financial objectives.
Conclusion
As we wrap up our discussion, GE HealthCare Technologies Inc. (GEHC) stands out as a strong choice in the healthcare field. Since separating from General Electric on January 4, 2023, it has made notable progress18. GEHC now boasts a market cap of $41.424 billion, a PE Ratio of 26.22, and has revenues of $19.52 billion, showing its financial strength2.
Looking closer at GEHC, it’s clear why investors find it attractive. With a return on equity of 21.22% and a net income of $1.58 billion, it’s a solid investment choice2. Even with price swings, hitting a high of $94.32 and a low of $72.61 in 2024, GEHC stays robust and flexible3.
To conclude, GEHC deserves attention for its past performance and future prospects. By examining its market outlook and financial details, investors can make informed choices. With positives like good earnings and a promising cost basis, GEHC is definitely worth considering for your stock portfolio182.